BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/21/2026 9:30:01 AM | Browse: 18 | Download: 0
| Category |
Psychiatry |
| Manuscript Type |
Minireviews |
| Article Title |
Antipsychotic-induced diabetes: Moving beyond obesity toward β-cell vulnerability
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Takahiko Nagamine |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Takahiko Nagamine, MD, PhD, Professor Emeritus, Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, 4-13-18 Jiyugaoka, Hofu 7470066, Japan. anagamine@yahoo.co.jp |
| Key Words |
Antipsychotic-induced diabetes; Schizophrenia; Clozapine; Olanzapine; β-cell dysfunction; Endoplasmic reticulum stress; Proinsulin misfolding; Glucagon-like peptide-1 receptor agonists; Precision medicine; Non-obese Asians |
| Core Tip |
Clinicians often view antipsychotic-induced diabetes as a consequence of obesity-linked insulin resistance. Yet, accumulating evidence reveals that clozapine and olanzapine directly impair pancreatic β-cell function via endoplasmic reticulum stress, proinsulin misfolding, and dedifferentiation, allowing diabetes to develop in lean individuals. This review presents an updated paradigm where obesity-dependent insulin resistance and intrinsic β-cell vulnerability co-exist. We highlight the metabolic susceptibility of East Asian populations, discuss how glucagon-like peptide-1 receptor agonists protect cell survival, and outline a precision medicine framework for metabolic risk management. |
| Citation |
Nagamine T. Antipsychotic-induced diabetes: Moving beyond obesity toward β-cell vulnerability. World J Psychiatry 2026; In press
|
 |
Received |
|
2026-07-08 08:44 |
 |
Peer-Review Started |
|
2026-07-08 08:45 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2026-08-11 07:14 |
 |
Revised |
|
2026-08-12 09:21 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-09-21 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-09-21 09:30 |
 |
Articles in Press |
|
2026-09-21 09:30 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.